CREBBP histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphoma.
British journal of haematology | 2024-11-01 | PMID 39188028
Kumar Emil Arjun, Korfi Koorosh, Bewicke-Copley Findlay and 17 more
